These factors are thought to ultimately result in the decreased production of tumor-antigen specific CD8+ T-cells and decreased clonal expansion to effector T cells and memory T-cells, that together can result in the immune-destruction of tumor cells. This evidence concerns the gene CD8A and neoplasm.